Back to Search
Start Over
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
- Source :
- GlobeNewswire. May 10, 2024
- Publication Year :
- 2024
-
Abstract
- Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines Agreement provides patients with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine [...]
- Subjects :
- Novavax Inc. -- Licensing agreements
Sanofi S.A. -- Licensing agreements
Biological products industry -- Licensing agreements
Biotechnology industry -- Licensing agreements
Influenza vaccines -- Licensing agreements
Influenza
Pharmaceutical industry -- Licensing agreements
Company licensing agreement
Banking, finance and accounting industries
Business
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.793262080